About
Pete O'Heeron is the chairman, founder, and CEO of FibroBiologics, a Houston-based clinical-stage biotechnology company developing fibroblast-based therapies for chronic diseases, cancer, wound healing, multiple sclerosis, orthopedics, and human-longevity-related programs. Company materials describe him as a long-time medical technology and biotech executive with 25+ years of experience and 350+ patents issued or pending. Before FibroBiologics, he founded Advanced Medical Technologies and NeoSurg Technologies, the latter of which was sold to Cooper Surgical in 2006.
Areas of interest
biotechregenerative medicinecell therapybiologicsmedical deviceshuman longevitymultiple sclerosiscancerorthopedicswound healing